Through exogenous administration of Nesfatin-1 to the model mice, we observed a significant reduction in blood glucose, body weight, and body size, coupled with improvements in diabetes-related characteristics, effectively correcting metabolic disorders in mice. This evidence concerns the gene NUCB2 and metabolic disease.